Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Afatinib/axitinib/linifanib - BioGene Pharmaceutical

Next Previous
X
Search
Drug Profile

Afatinib/axitinib/linifanib - BioGene Pharmaceutical

Alternative Names: Vaginal suppository ELTA - BioGene Pharmaceutical

Latest Information Update: 28 Feb 2022

Price :

$50 *

Note:
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator BioGene Pharmaceutical
  • Class Imidazoles; Indazoles; Phenylurea compounds; Quinazolines; Small molecules
  • Mechanism of Action Angiogenesis inhibitors; Epidermal growth factor receptor antagonists; ERBB 2 receptor antagonists; ERBB 4 receptor antagonists; Platelet-derived growth factor beta receptor antagonists; Platelet-derived growth factor receptor antagonists; Protein tyrosine kinase inhibitors; Proto-oncogene protein c-kit inhibitors; Vascular endothelial growth factor receptor-1 antagonists; Vascular endothelial growth factor receptor-2 antagonists; Vascular endothelial growth factor receptor-3 antagonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • No development reported Endometriosis

Most Recent Events

  • 28 Feb 2022 No recent reports of development identified for preclinical development in Endometriosis in Switzerland (Rectal, Suppository)
  • 16 Apr 2018 BioGene Pharmaceutical plans a phase I trial for Endometriosis in Switzerland, in May 2018 (NCT03481842)
  • 01 Jan 2018 Preclinical trials in Endometriosis in Switzerland (Rectal)

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top